214 related articles for article (PubMed ID: 28655784)
1. Inhibition of Megakaryocyte Differentiation by Antibody-Drug Conjugates (ADCs) is Mediated by Macropinocytosis: Implications for ADC-induced Thrombocytopenia.
Zhao H; Gulesserian S; Ganesan SK; Ou J; Morrison K; Zeng Z; Robles V; Snyder J; Do L; Aviña H; Karki S; Stover DR; Doñate F
Mol Cancer Ther; 2017 Sep; 16(9):1877-1886. PubMed ID: 28655784
[TBL] [Abstract][Full Text] [Related]
2. Potential mechanisms for thrombocytopenia development with trastuzumab emtansine (T-DM1).
Uppal H; Doudement E; Mahapatra K; Darbonne WC; Bumbaca D; Shen BQ; Du X; Saad O; Bowles K; Olsen S; Lewis Phillips GD; Hartley D; Sliwkowski MX; Girish S; Dambach D; Ramakrishnan V
Clin Cancer Res; 2015 Jan; 21(1):123-33. PubMed ID: 25370470
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Macropinocytosis-Mediated Internalization Decreases Ocular Toxicity of Antibody-Drug Conjugates.
Zhao H; Atkinson J; Gulesserian S; Zeng Z; Nater J; Ou J; Yang P; Morrison K; Coleman J; Malik F; Challita-Eid P; Karki S; Aviña H; Hubert R; Capo L; Snyder J; Moon SJ; Luethy R; Mendelsohn BA; Stover DR; Doñate F
Cancer Res; 2018 Apr; 78(8):2115-2126. PubMed ID: 29382707
[TBL] [Abstract][Full Text] [Related]
4. A Potential Mechanism for ADC-Induced Neutropenia: Role of Neutrophils in Their Own Demise.
Zhao H; Gulesserian S; Malinao MC; Ganesan SK; Song J; Chang MS; Williams MM; Zeng Z; Mattie M; Mendelsohn BA; Stover DR; Doñate F
Mol Cancer Ther; 2017 Sep; 16(9):1866-1876. PubMed ID: 28522588
[TBL] [Abstract][Full Text] [Related]
5. T-DM1-induced thrombocytopenia in breast cancer patients: New perspectives.
Liu F; Ke J; Song Y
Biomed Pharmacother; 2020 Sep; 129():110407. PubMed ID: 32570117
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo efficacy of an anti-CD203c conjugated antibody (AGS-16C3F) in mouse models of advanced systemic mastocytosis.
Zhang Y; Wedeh G; He L; Wittner M; Beghi F; Baral V; Launay JM; Bibi S; Doñate F; Kouros-Mehr H; Arock M; Louache F
Blood Adv; 2019 Feb; 3(4):633-643. PubMed ID: 30804017
[TBL] [Abstract][Full Text] [Related]
7. RUNX1 and TGF-β signaling cross talk regulates Ca
Raghuwanshi S; Dahariya S; Sharma DS; Kovuru N; Sahu I; Gutti RK
FEBS J; 2020 Dec; 287(24):5411-5438. PubMed ID: 32281291
[TBL] [Abstract][Full Text] [Related]
8. Caspase activation is involved in early megakaryocyte differentiation but not in platelet production from megakaryocytes.
Kozuma Y; Yuki S; Ninomiya H; Nagasawa T; Kojima H
Leukemia; 2009 Jun; 23(6):1080-6. PubMed ID: 19212331
[TBL] [Abstract][Full Text] [Related]
9. Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas.
Thompson JA; Motzer RJ; Molina AM; Choueiri TK; Heath EI; Redman BG; Sangha RS; Ernst DS; Pili R; Kim SK; Reyno L; Wiseman A; Trave F; Anand B; Morrison K; Doñate F; Kollmannsberger CK
Clin Cancer Res; 2018 Sep; 24(18):4399-4406. PubMed ID: 29848572
[No Abstract] [Full Text] [Related]
10. In vitro large scale production of megakaryocytes to functional platelets from human hematopoietic stem cells.
Kumar PS; Chandrasekhar C; Srikanth L; Sarma PVGK
Biochem Biophys Res Commun; 2018 Oct; 505(1):168-175. PubMed ID: 30243726
[TBL] [Abstract][Full Text] [Related]
11. Generation of functional platelets from canine induced pluripotent stem cells.
Nishimura T; Hatoya S; Kanegi R; Sugiura K; Wijewardana V; Kuwamura M; Tanaka M; Yamate J; Izawa T; Takahashi M; Kawate N; Tamada H; Imai H; Inaba T
Stem Cells Dev; 2013 Jul; 22(14):2026-35. PubMed ID: 23409943
[TBL] [Abstract][Full Text] [Related]
12. Quinine-induced thrombocytopenia: drug-dependent GPIb/IX antibodies inhibit megakaryocyte and proplatelet production in vitro.
Perdomo J; Yan F; Ahmadi Z; Jiang XM; Stocker R; Chong BH
Blood; 2011 Jun; 117(22):5975-86. PubMed ID: 21487107
[TBL] [Abstract][Full Text] [Related]
13. Nanocurcumin as a novel stimulator of megakaryopoiesis that ameliorates chemotherapy-induced thrombocytopenia in mice.
Mortazavi Farsani SS; Sadeghizadeh M; Gholampour MA; Safari Z; Najafi F
Life Sci; 2020 Sep; 256():117840. PubMed ID: 32450173
[TBL] [Abstract][Full Text] [Related]
14. G-CSF administration results in thrombocytopenia by inhibiting the differentiation of hematopoietic progenitors into megakaryocytes.
Li Y; Guo R; Wang L; Li S; Zhu Z; Tu P
Biochem Pharmacol; 2019 Nov; 169():113624. PubMed ID: 31473203
[TBL] [Abstract][Full Text] [Related]
15. High-content live-cell imaging assay used to establish mechanism of trastuzumab emtansine (T-DM1)--mediated inhibition of platelet production.
Thon JN; Devine MT; Jurak Begonja A; Tibbitts J; Italiano JE
Blood; 2012 Sep; 120(10):1975-84. PubMed ID: 22665936
[TBL] [Abstract][Full Text] [Related]
16. A Randomized Phase II Study of AGS-16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma.
Kollmannsberger C; Choueiri TK; Heng DYC; George S; Jie F; Croitoru R; Poondru S; Thompson JA
Oncologist; 2021 Mar; 26(3):182-e361. PubMed ID: 33289953
[TBL] [Abstract][Full Text] [Related]
17. Efficient generation of megakaryocytes from human induced pluripotent stem cells using food and drug administration-approved pharmacological reagents.
Liu Y; Wang Y; Gao Y; Forbes JA; Qayyum R; Becker L; Cheng L; Wang ZZ
Stem Cells Transl Med; 2015 Apr; 4(4):309-19. PubMed ID: 25713465
[TBL] [Abstract][Full Text] [Related]
18. AGS16F Is a Novel Antibody Drug Conjugate Directed against ENPP3 for the Treatment of Renal Cell Carcinoma.
Doñate F; Raitano A; Morrison K; An Z; Capo L; Aviña H; Karki S; Morrison K; Yang P; Ou J; Moriya R; Shostak Y; Malik F; Nadell R; Liu W; Satpayev D; Atkinson J; Joseph IB; Pereira DS; Challita-Eid PM; Stover DR
Clin Cancer Res; 2016 Apr; 22(8):1989-99. PubMed ID: 26589436
[TBL] [Abstract][Full Text] [Related]
19. Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation.
Huang J; Huang S; Ma Z; Lin X; Li X; Huang X; Wang J; Ye W; Li Y; He D; Yang M; Pan J; Ling Q; Li F; Mao S; Wang H; Wang Y; Jin J
Thromb Haemost; 2021 Feb; 121(2):192-205. PubMed ID: 32961571
[TBL] [Abstract][Full Text] [Related]
20. GSK-3β negatively regulates megakaryocyte differentiation and platelet production from primary human bone marrow cells in vitro.
Ono M; Matsubara Y; Shibano T; Ikeda Y; Murata M
Platelets; 2011; 22(3):196-203. PubMed ID: 21231855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
